ID: ALA1224117

Max Phase: Preclinical

Molecular Formula: C28H23Cl2N3O7S

Molecular Weight: 616.48

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)[C@H](Cc1ccc(OCc2c(Cl)cccc2Cl)cc1)NC(=O)[C@@H]1OCO[C@H]1C(=O)Nc1nc2ccccc2s1

Standard InChI:  InChI=1S/C28H23Cl2N3O7S/c29-18-4-3-5-19(30)17(18)13-38-16-10-8-15(9-11-16)12-21(27(36)37)31-25(34)23-24(40-14-39-23)26(35)33-28-32-20-6-1-2-7-22(20)41-28/h1-11,21,23-24H,12-14H2,(H,31,34)(H,36,37)(H,32,33,35)/t21-,23+,24+/m0/s1

Standard InChI Key:  NXXULCNLVLCQMW-QPTUXGOLSA-N

Associated Targets(Human)

Integrin alpha-4 295 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 616.48Molecular Weight (Monoisotopic): 615.0634AlogP: 4.67#Rotatable Bonds: 10
Polar Surface Area: 136.08Molecular Species: ACIDHBA: 8HBD: 3
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.58CX Basic pKa: CX LogP: 5.55CX LogD: 1.99
Aromatic Rings: 4Heavy Atoms: 41QED Weighted: 0.23Np Likeness Score: -1.08

References

1. Rehman A, Soni A, Naik K, Nair S, Palle VP, Dastidar S, Ray A, Alam MS, Salman M, Cliffe IA, Sattigeri V..  (2010)  Synthesis and biological activity of N-substituted aminocarbonyl-1,3-dioxolanes as VLA-4 antagonists.,  20  (18): [PMID:20705461] [10.1016/j.bmcl.2010.07.069]

Source